Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Symptomatic Knee Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update evaluates the safety and efficacy of 2ccPA for symptomatic knee osteoarthritis in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Osteoarthritis

Drugs mentioned

• 2ccPA (2ccPA)

Snippet

Sponsor: Orient Europharma Co., Ltd. | Conditions: Osteoarthritis, Knee | Phase 1, Phase 2 | Status: UNKNOWN